IP Library Assignment 057919/0429
Patent Assignment
Reel/Frame 057919/0429

Assignment of Assignor's Interest

Recorded: 2021-10-26 Pages: 7
Assignors
JONES, PHILIP
Executed: 2019-08-15
CZAKO, BARBARA
Executed: 2019-08-15
CARROLL, CHRISTOPHER L.
Executed: 2019-08-15
MANDAL, PIJUS
Executed: 2019-08-15
CROSS, JASON
Executed: 2019-08-15
Assignee
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
210 WEST 7TH STREET, AUSTIN, TEXAS, 78701
Covered Property (1)
PTPN11 Inhibitors
Application: 17/380,943 →
Publication: US 2022/0041594
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 26, 2021
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 057919/0638 →
Security Interest Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →
Assignment of Assignor's Interest Sep 4, 2025
From: NAVIRE PHARMA, INC.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 072160/0110 →